Neogen Corporation Inventory, Raw Materials, Net of Reserves
Neogen Corporation (NEOG) had Inventory, Raw Materials, Net of Reserves of $51.10 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2026-07-30
- 2026-05-31: Inventory, Raw Materials, Net of Reserves $51.10M.
- 2025-05-31: Inventory, Raw Materials, Net of Reserves $65.70M; Inventory, Raw Materials, Net of Reserves as first filed $65.69M.
- 2024-05-31: Inventory, Raw Materials, Net of Reserves $78.80M.
- 2024-02-29: Inventory, Raw Materials, Net of Reserves $70.14M.
| Period end | Inventory, Raw Materials, Net of Reserves | Inventory, Raw Materials, Net of Reserves as first filed |
|---|---|---|
| 2026-05-31 | $51.10M 10-K · filed 2026-07-30 | |
| 2025-05-31 | $65.70M 10-K · filed 2026-07-30 | $65.69M 10-K · filed 2025-07-30 |
| 2024-05-31 | $78.80M 10-K · filed 2025-07-30 | |
| 2024-02-29 | $70.14M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $67.77M 10-Q · filed 2024-01-09 | |
| 2023-08-31 | $64.69M 10-Q · filed 2023-10-10 | |
| 2023-05-31 | $66.62M 10-K · filed 2024-07-30 | $64.97M 10-K · filed 2023-08-15 |
| 2023-02-28 | $73.51M 10-Q · filed 2023-04-04 | |
| 2022-11-30 | $68.88M 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $62.13M 10-Q · filed 2022-09-30 | |
| 2022-05-31 | $58.67M 10-K · filed 2023-08-15 | |
| 2022-02-28 | $54.75M 10-Q · filed 2022-04-01 | |
| 2021-11-30 | $53.94M 10-Q · filed 2021-12-30 | |
| 2021-08-31 | $50.24M 10-Q · filed 2021-09-30 | |
| 2021-05-31 | $47.59M 10-K · filed 2022-07-27 | |
| 2021-02-28 | $46.42M 10-Q · filed 2021-03-31 | |
| 2020-11-30 | $45.27M 10-Q · filed 2020-12-29 | |
| 2020-08-31 | $47.59M 10-Q · filed 2020-09-30 | |
| 2020-05-31 | $45.06M 10-K · filed 2021-07-30 | |
| 2020-02-29 | $42.24M 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $43.32M 10-Q · filed 2019-12-27 | |
| 2019-08-31 | $42.96M 10-Q · filed 2019-09-26 | |
| 2019-05-31 | $41.59M 10-K · filed 2020-07-30 | |
| 2019-02-28 | $38.94M 10-Q · filed 2019-03-29 | |
| 2018-11-30 | $36.56M 10-Q · filed 2018-12-28 | |
| 2018-08-31 | $36.01M 10-Q · filed 2018-10-05 | |
| 2018-05-31 | $36.70M 10-K · filed 2019-07-30 | |
| 2018-02-28 | $35.77M 10-Q · filed 2018-03-29 | |
| 2017-11-30 | $35.91M 10-Q · filed 2018-01-05 | |
| 2017-08-31 | $34.36M 10-Q · filed 2017-09-29 | |
| 2017-05-31 | $33.19M 10-K · filed 2018-07-27 | |
| 2017-02-28 | $33.38M 10-Q · filed 2017-03-31 | |
| 2016-11-30 | $31.88M 10-Q · filed 2016-12-29 | |
| 2016-08-31 | $31.21M 10-Q · filed 2016-09-30 | |
| 2016-05-31 | $29.50M 10-K · filed 2017-07-28 | |
| 2016-02-29 | $27.87M 10-Q · filed 2016-03-31 | |
| 2015-11-30 | $26.57M 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $24.21M 10-Q · filed 2015-09-30 | |
| 2015-05-31 | $21.61M 10-K · filed 2016-07-29 | |
| 2015-02-28 | $23.18M 10-Q · filed 2015-04-01 | |
| 2014-11-30 | $21.33M 10-Q · filed 2014-12-30 | |
| 2014-08-31 | $22.12M 10-Q · filed 2014-09-30 | |
| 2014-05-31 | $21.52M 10-K · filed 2015-07-30 | |
| 2014-02-28 | $22.26M 10-Q · filed 2014-04-04 | |
| 2013-11-30 | $20.52M 10-Q · filed 2014-01-09 | |
| 2013-08-31 | $18.58M 10-Q · filed 2013-09-30 | |
| 2013-05-31 | $16.59M 10-K · filed 2014-07-30 | |
| 2012-05-31 | $14.00M 10-K · filed 2013-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |